BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 69006)

  • 1. Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells.
    Forman J
    J Exp Med; 1977 Aug; 146(2):600-5. PubMed ID: 69006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
    Forman J
    J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymus cells suppress the in vitro cytotoxic response against trinitrophenyl (TNP) modified syngeneic cells.
    Hurme M; Bång BE
    Scand J Immunol; 1981; 13(1):35-40. PubMed ID: 6972089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
    Henkart PA; Schmitt-Verhulst M; Shearer GM
    J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared determinants between virus-infected and trinitrophenyl-conjugated H-2-identical target cells detected in cell-mediated lympholysis.
    Starzinski-Powitz A; Pfizenmaier K; Koszinowski U; Röllinghoff M; Wagner H
    Eur J Immunol; 1976 Sep; 6(9):630-4. PubMed ID: 63379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay.
    Forman J; Vitetta ES; Hart DA
    J Immunol; 1977 Mar; 118(3):803-8. PubMed ID: 66273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
    Forman J; Vitetta ES; Hart DA; Klein J
    J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
    Burakoff SJ; Germain RN; Benacerraf B
    J Exp Med; 1976 Dec; 144(6):1609-20. PubMed ID: 1087327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
    Fujiwara H; Levy RB; Shearer GM
    Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.
    Wilson DB; Lindahl KF; Wilson DH; Sprent J
    J Exp Med; 1977 Aug; 146(2):361-7. PubMed ID: 301550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.
    Schmitt-Verhulst AM; Pettinelli CB; Henkart PA; Lunney JK; Shearer GM
    J Exp Med; 1978 Feb; 147(2):352-68. PubMed ID: 75237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of self-carriers in the immune response and tolerance. I. B-cell unresponsiveness and cytotoxic T-cell immunity induced by haptenated syngeneic lymphoid cells.
    Scott DW; Long CA
    J Exp Med; 1976 Nov; 144(5):1369-74. PubMed ID: 1086885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
    Forman J
    J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants.
    Fujiwara H; Tsuchida T; Levy RB; Shearer GM
    J Immunol; 1982 Sep; 129(3):1189-93. PubMed ID: 6179996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.
    Abbas AK; Ratnofsky SE; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2):306-23. PubMed ID: 6156985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells.
    Finberg R; Greene MI; Benacerraf B; Burakoff SJ
    J Immunol; 1979 Sep; 123(3):1205-9. PubMed ID: 89164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes.
    Starzinski-Powitz A; Pfizenmaier K; Röllinghoff M; Wagner H
    Eur J Immunol; 1976 Nov; 6(11):799-805. PubMed ID: 1087237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.